Share New England Biolabs® and Mammoth Biosciences® Announce Global Licensing Agreement and Commercial Launch of MB-CasFire™ to Accelerate Isothermal Amplification-Based Assay Development

PRNewsWire · November 10, 2026

New England Biolabs® and Mammoth Biosciences® Announce Global Licensing Agreement and Commercial Launch of MB-CasFire™ to Accelerate Isothermal Amplification-Based Assay Development

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: PRNewsWire ↗